Enfoque clínico | 13 JUL 15

Fiebre de origen desconocido

En la fiebre de origen desconocido es importante hacer un diagnóstico precoz porque cuanto más tiempo se tarda en hacerlo menor es la probabilidad de arribar al diagnóstico definitivo.
INDICE:  1.  | 2. Referencias
Referencias

1. Cunha CB, Prolonged and perplexing fevers in antiquity: malaria and typhoid Fever. Infect Dis Clin North Am 2007;21:857-866.
2. Cunha BA. Fever of Unknown Origin: clinical overview and perspective. In: Cunha BA (Editor) Fever of Unknown Origin. Informa Healthcare New York 2007:pp.1-8.
3. Petersdorf RG, Beeson PB. Fever of Unexplained Origin: Report on 100 cases. Medicin 1961;40:1-30.
4. Durack D, Street A. Fever of unknown origin: reexamined and redefined. Curr Clin Top Infect Dis 1991;11:35-51.
5. Larson EB, Featherstone HJ, Petersdorf RG. Fever of undetermined origin: diagnosis and follow-up of 105 cases, 1970-80. Medicine 1982;61:269-292.
6. Molavi A, Weinstein L. Persistent perplexing pyrexia. Some comments on etiology and diagnosis. Med Clin North Am 1970;54:379-396.
7. Louria DB. Fever of unknown etiology. Del Med J 1971;43:343-348.
8. Jacoby GA, Swartz MN. Fever of undetermined origin. N Engl J Med 1973;289:1407-1410. 9. Tumulty PA, (Editor). The Patient with Fever of Unknown Origin: The Effective Clinician. Philadelphia: WB Saunders, 1973;pp.137-170.
10. Cunha BA. Fever of unknown origin. Infect Dis Clin North Am 1996;10:111-128.
11. Lortholary O, Bletry LG, Godeau P. Fever of unknown origin: a retrospective multicentre study of 103 cases, 1980 – 88. Eur J Med 1992;3:109-120.
12. Brusch JL, Weinstein L. Fever of unknown origin. Med Clin North Am 1988;72:1247-1261. 13. Knockaert DC, Vanderschueren S, Blockmans D. Fever of unknown origin in Adults: 40 years on. J Intern Med 2003;263-275.
14. Bryan CS. Fever of unknown origin. Arch Intern Med 2003;163:1003-1004.
15. Arnow PM, Flaherty JP. Fever of unknown origin. Lancet. 1997;350:575-580.
16. Nubile MJ. Acute fevers of unknown origin. A plea for restraint. Arch Intern Med 1993;153:2525-2526.
17. Vanderschueren S, Knockaert D, Adriaenssens T, et al. From prolonged febrile illness to fever of unknown origin: The Challenge Continues. Arch Intern Med 2003;163:1033-1041. 18. Ergonul O, Wilke A, Azap A, et al. Revised definition of fever of unknown origin: Limitations and opportunities.treated in community hospital. Clin Infect Dis 1992;15:968-973.
22. Wang C, Armstrong D. Neoplastic Diseases. In: Murray HW, (Editor). Fever of Unknown Origin of Undetermined Origin. Mount Kisco; Futura Publishing, 1983; pp. 39-48.
 23. Cunha BA. Fever of unknown origin in malignancies. In: Cunha BA, (Editor). Fever of Unknown Origin. New York, Informa Healthcare, 2007;pp.27-34.
24. Zhang J, Chen B, Xu X, Lin Z, Huang B, Song J, et al. Clinical features of 66 lymphoma patients presenting with a fever of unknown origin. Intern Med. 2012;51:2529-2536.
25. Cunha BA. Fever of Unknown Origin: focused diagnostic approach based on clinical clues from the history, physical examination and laboratory tests. Infect Dis Clin North Am 2007;21:1137-1188.
26. Manfredi R, Calza L, Chiodo F. Primary cytomegalovirus infection in otherwise healthy adults with fever of unknown origin: a 3-year prospective survey. Infection 2006;34:87-90.
27. Cunha BA. Fever of unknown origin. In: Gorbach SL, Bartlett JG, Blacklow NE, (Editors). Infectious Diseases. (3rd Ed) Philadelphia: Lippincott Williams & Wilkins 2005;1568-1577.
28. Carsons SE. Fever in rheumatic and autoimmune disease. Infect Dis Clin North Am 1996;10:67-84.
29. Zenone T. Fever of Unknown Origin in rheumatic diseases. Infect Dis Clin North Am 2007;21:1115-1136.
30. Cunha BA. Fever of unknown origin in rheumatic diseases. In: Cunha BA, Editor. Fever of Unknown Origin. New York, Informa Healthcare 2007;pp.59-64.
31. Cunha BA, Parchuri S, Mohan S. Fever of unknown origin: temporal arteritis presenting with persistent cough and elevated serum ferritin levels. Heart & Lung 2006;35:112-116.
32. Cunha BA, Nausheen S. Fever of unknown origin due to cyclic neutropenia with relative bradycardia. Heart & Lung 2009;38:350-353.
33. Cunha BA, Mickail N, Durie N, Pherez FM, Strollo S. Fever of unknown origin caused by Kikuchi’s disease mimicking lymphoma. Heart & Lung 2009;38:450-456.
34. Cunha BA, Durie N, Selbs E, Pherez F. Fever of unknown origin due to Rosai-Dorfman disease with mediastinal adenopathy mimicking lymphoma: diagnostic importance of elevated serum ferritin levels and polyclonal gammopathy. Heart & Lung 2009;38:83-88.
35. Brendan MW, Matthew JH, Dennis PM. Subacute thyroiditis manifesting as fever of unknown
origin. South Med J 2000;93:926-929.
36. Cunha BA, Thermidor M, Mohan S, et al. Fever of unknown origin: subacute thyroiditis versus typhoid fever. Heart & Lung 2005;34:147-151.
37. Cunha BA, Chak A, Strollo S. Fever of unknown origin: de Quervain’s subacute thyroiditis with highly elevated ferritin levels mimicking temporal arteritis (TA). Heart & Lung 2010;39:73-77.
38. Cunha BA, Berbari N. Subacute thyroiditis (de Quervain’s) due to influenza A: presenting asfever of unknown origin. Heart & Lung 2013;42:77-78.
39. Murray HW. Factitious fever updated. Arch Intern Med 1979;139:739-740.
40. Johnson DH, Cunha BA. Drug fever. Infect Dis Clin North Am 1996;10:85-92.
41. Drenth JPH, Haagsma CJ, van der Meer JWM, and the International Hyper-IgD study group. Hyperimmunoglobulinemia D and periodic fever syndrome.The clinical spectrum in a series of 50 patients. Medicine 1994;73:133-144.
42. Wolf SM, Fauci AS, Dale DC. Unusual etiologies of fever and their evaluation. Annual Rev Med 1975;26:277-281.
43. Norman DC, Wong MB. Fever of unknown origin in older persons. In: Cunha BA (Editor) Fever of Unknown Origin. New York: Informa Healthcare 2007;pp.109-114.
44. Cunha BA. Diagnostic significance of relative bradycardia. Clin Microbiol Infect 2000;6:633-634.
45. Cunha CB. Infectious disease differential diagnosis. In: Cunha BA (Editor). Antibiotic Essentials (12th Ed) Sudbury MA, Jones & Bartlett. 2013;pp. 472-504.
46. Cunha CB, Wilkinson MJ, Quillen DA. Ophthalmologic clues to infectious diseases. In Cunha BA, (Editor). Infectious Diseases in Critical Care Medicine (3rd Ed.) New York, Informa
2010;pp. 66-75.
47. Cunha BA. The mimics of endocarditis. In: Brusch JL, (Editor). Infective Endocarditis: Management in the Era of Intravascular Devices. New York: Informa Healthcare, 2006; pp.345-354.
48. Esposito AL, Gleckman RA. A diagnostic approach to the adult with fever of unknown origin. Arch Intern Med 1979;139:575-578.
49. Esposito AL. Planning and proceeding with the diagnostic evaluation. In: Murray HW (Editor) Fever of Undetermined Origin. Mount Kisco: Futura Publishing 1983;pp.141-145.
50. Cunha BA. Fever of unknown origin: a focused diagnostic approach. In: Cunha BA (Editor) Fever of Unknown Origin. New York Informa Healthccare 2007;pp.9-16.
51. Cunha BA. The diagnostic significance of fever curves. Infect Dis Clin North Am 1996;10:33-44.
52. Cunha BA, Krakakis J, McDermott BP. Fever of unknown origin caused by military tuberculosis: diagnostic significance of morning temperature spikes. Heart & Lung 2009; 38:77-82.
53. Cunha BA. Fever of unknown origin caused by adult juvenile rheumatoid arthritis: the diagnostic significance of double quotidian fevers and elevated serum ferritin levels. Heart & Lung 2004:33:417-421.
54. Cunha BA, Hage JE, Nouri Y. Recurrent fever of unknown origin : aseptic meningitis, hepatosplenomegaly, pericarditis and a double quotidian fever due to juvenile rheumatoid arthritis (JRA). Heart & Lung 2012;41:177-180.
55. Cunha BA. Nonspecific tests in the diagnosis of fever of unknown origin. In: Cunha BA, (Editor). Fever of unknown origin. New York Informa Healthcare 2007; pp.151-158.
56. Purnendu S, Louria DB. Non-invasive and invasive diagnostic procedures and laboratory methods. In: Henry W Murray (Editor). Fever of Unknown Origin Fever of undetermined origin. Mount Kisco: Futura Publishing; 1983; pp.159-190.
57. Cunha BA, Petelin A. Fever of unknown origin due to large B-cell lymphoma: the diagnostic significance of highly elevated alkaline phosphatase and serum ferritin levels. Heart & Lung 2013;42:67-71.
58. Cunha BA. Fever of unknown origin : diagnostic importance of serum ferritin levels. Scan J Infect Dis 2007;39:651-652.
59. Kosmin A, Lorber B. Specific tests in the diagnosis of fever of unknown origin. In: Cunha BA (Editor) Fever of Unknown Origin. New York, Informa Healthcare 2007;159-208.
60. Chang JC, Gross HM. Utility of naproxen in the differential diagnosis of fever of undetermined origin in patients with cancer. Am J Med 1984;76:597-603.
61. Cunha BA, Bouyarden M, Hamid N. Multiple myeloma presenting as a fever of unknown Origin: The diagnostic importance of the naprosyn test. Heart & Lung 2006;35:358-362.
62. Trivedi Y, Yung E, Katz DS. Imaging in fever of unknown origin. In: Cunha BA, (Editor). Fever of unknown origin. New York Informa Healthcare 2007;pp.209-228.
63. Pedersen TI, Roed C, Knudsen LS, Loft A, Skinhoj P, Nielsen SD. Fever of unknown origin: a retrospective study of 52 cases with evaluation of the diagnostic utility of FDG-PET/CT. Scand J Infect Dis 2012;44:18-23.
64. Ben-Baruch S, Canaani J, Braunstein R, et al. Predictive parameters for a diagnostic bone marrow biopsy specimen in the work-up of fever of unknown origin. Mayo Clin Proc 2012;87:136-142.
65. Jha A, Sarda R, Gupta A, Talwar OP. Bone marrow culture vs blood culture in Fever of Unknown Origin. J Nepal Med Assoc 2009;48:135-138.
66. DeKleijn EM, van Lier HJ, van der Meer JW. Fever of unknown origin (. II. Diagnostic procedures in a prospective multicenter study of 167 patients. The Netherlands Fever of Unknown Origin Study Group. Medicine 1997;76:401-414.
67. Zenone T. Fever of unknown origin in adults: evaluation of 144 cases in a non-university hospital. Scand J Infect Dis 2006;38:625-631.
68. Mayo J, Collazos J, Martinez E. Fever of unknown origin in the HIV-infected patient: new scenario for an old problem. Scand J Infect Dis. 1997;29:327-336.
69. Armstrong WS, Katz JT, Kazanjian PH. Human immunodeficiency virus-associated fever of unknown origin: a study of 70 patients in the United States and review. Clin Infect Dis. 1999;28:341-345.
70. Hot A, Schmulewitz L, Viard JP, Lortholary O. Fever of unknown origin in HIV/AIDS patients. Infect Dis Clin N Am 2007; 21:1013-1032.
71. Miralles P, Moreno S, Perez-Tascon M, Cosin J, Diaz MD, Bouza E. Fever of uncertain origin in patients infected with the human immunodeficiency virus. Clin Infect Dis. 1995;20:872-875.
72. Lozano F, Torre-Cisneros J, Santos J, et al. Impact of highly active antiretroviral therapy on
fever of unknown origin in HIV-infected patients. Eur J Clin Microbiol Infect Dis. 2002;21:137-139.
73. Havlir DV, Barnes PF. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med. 1999;340:367-373.
74. Park BJ et al. Estimation of the current global burden of cryptococcal meningitis among personsliving with HIV/AIDS. AIDS 2009;23: 525-30.
75. Micol R et al. Prevalence, risk factors, and impact on outcome of cytomegalovirus replication in serum of Cambodian HIV-infected patients (2004-2007). J Acquir Immune Defic Syndr 2009;51: 486-491.
76. Nokta MA, Holland F, De Gruttola V, et al. Cytomegalovirus polymerase chain reaction profiles in individuals with advanced human immunodeficiency virus infection: relationship to cytomegalovirus disease. J Infect Dis. 2002;185:1717-1722.
77. Deayton JR, Prof Sabin CA, Johnson MA, Emery VC, Wilson P, Griffiths PD. Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy. Lancet. 2004;363:2116-2121.
78. Peigne V et al. Imported acquired immunodeficiency syndrome-related histoplasmosis in metropolitan France: a comparison of pre-highly active anti-retroviral therapy and highly active anti-retroviral therapy eras. Am J Trop Med Hyg 2011; 85: 934-41.
79. Wheat LJ, Connolly-Stringfield PA, Baker RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore). 1990;69:361-374.
80. Woods CW, McRill C, Plikaytis BD, et al. Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994-1997: incidence, risk factors, and prevention. J Infect Dis. 2000;181:1428-1434.
81. Fish DG, Ampel NM, Galgiani JN, et al. Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients. Medicine (Baltimore). 1990;69:384-391.
82. Wong SS, Wong KH, Hui WT, et al. Differences in clinical and laboratory diagnostic characteristics of penicilliosis marneffei in human immunodeficiency virus (HIV)- and non-HIV-infected patients. J Clin Microbiol. 2001;39:4535-4540.
83. Jarvis JN, Lockwood DN. Clinical aspects of visceral leishmaniasis in HIV infection. Curr Opin Infect Dis 2013; 26: 1-9.
84. Zylberberg H, Robert F, Le Gal FA, Dupouy-Camet J, Zylberberg L, Viard JP. Prolonged isolated fever due to attenuated extracerebral toxoplasmosis in patients infected with human immunodeficiency virus who are receiving trimethoprim-sulfamethoxazole as prophylaxis. Clin Infect Dis. 1995;21:680-681.
85. Koehler JE, Sanchez MA, Tye S, et al. Prevalence of Bartonella infection among human immunodeficiency virus-infected patients with fever. Clin Infect Dis. 2003;37:559-566.
86. Lortholary O, Meyohas MC, Dupont B, et al. Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS. Am J Med. 1993;95:177-187.
87. Goedert JJ, Cote TR, Virgo P, et al. Spectrum of AIDS-associated malignant disorders. Lancet. 1998;351:1833-1839.
88. Cribb AE, Lee BL, Trepanier LA, Spielberg SP. Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: clinical syndromes and pathogenesis. Adverse Drug React Toxicol Rev. 1996;15:9-50.
89. Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet. 2000;356:1423-1430
90. Fellay J, Boubaker K, Ledergerber B, et al. Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet. 2001;358:1322-1327.
91. Shelburne SA, Visnegarwala F, Darcourt J, et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS. 2005;19:399-406.
92. Bouza E, Loeches B, Munoz P. Fever of Unknown Origin in Solid Organ Transplant Recipients. In: Cunha BA (Editor) Fever of Unknown Origin. Informa Healthcare New York 2007:79-100.
93. Bonham CA, Dominguez EA, Fukui MB, et al. Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management. Transplantation 1998;66:1596-1604.
94. Ionescu DN, Dacic S. Persistent fever in a lung transplant patient. Arch Pathol Lab Med 2005;129:e153-154.
95. Wulf MW, van Crevel R, Portier R, et al. Toxoplasmosis after renal transplantation: implications of a missed diagnosis. J Clin Microbiol 2005;43:3522-3547.
96. Maegraith B. Unde venis? Lancet 1963;1:401-403.
97. Saxe SE, Gardner P. The returning traveler with fever. Infect Dis Clin North Am 1992;6:427-439.
98. Speil C, Mushtaq A, Adamski A, Khardori N. Fever of Unknown Origin in the Returning Traveler. Infect Dis Clin North Am. 2007:1091-1114.
99. Cleri DJ, Ricketti AJ, Vernaleo JR. Fever of Unknown Origin Due to Zoonoses. Infect Dis Clin North Am. 2007;21:963-996.
100. Botelho-Nevers E, Raoult D. Fever of Unknown Origin due to rickettsioses. Infect Dis Clin North Am. 2007;21:997-1011.
101. O’Brien D, Tobin S, Brown GV, et al. Fever in returned travelers: review of hospital admissions for a 3-year period. Clin Infect Dis 2001;5:603-609.
102. Lortholary O, Charlier C, Lebeaux D, Lecuit M, Consigny PH. Fungal infections in immunocompromised travelers. Clin Infect Dis 2013; 56: 861-9.
103. Knockaert DC, Durjardin KS, Bobbaers HJ. Long-term follow-up of patients with undiagnosed fever of unknown origin. Arch Intern Med 1996;156:618-620.
104. Collazos, J, Guerra E, Mayo J, et al. Tuberculosis as a cause of recurrent fever of unknown origin. J Infect 2000;41:269-272.
105. Lekstrom-Himes JA, Dale JK, Kingma DW, et al. Periodic illness associated with Epstein-Barr virus infection. Clin Infect Dis 1996;22:22-27.
106. Munoz-Gomez S, Cunha BA. Recurrent Fever of Unknown Origin in an adult due to FAPA syndrome. J Clin Med 2013;2:45-48.
107. Weinstein L. Clinically benign fever of Unknown Origin: A personal retrospective. Rev Infect Dis 1985;7:692-699.
108. Knockaert, DC. Recurrent Fevers of Unknown Origin. Infect Dis Clin North Am 2007;21:1189-1211.
109. Bryan CS, Ahuja D. Fever of Unknown Origin: Is there a role for empiric therapy. Infect Dis Clin North Am. 2007;21:1213-1220.
110. Eiko LM, Bryan CS. Empiric therapy in Fever of Unknown Origin: a cautionary note. In: Cunha BA (Editor) Fever of Unknown Origin. New York. Informa Healthcare. 2007:pp.229-236.

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024